Superworth

DataMeds AI MEDS

Medical - Distribution, Healthcare
$1.83
−4.69%
Market cap
$5.6M
PE
n/m
a loss over the last year
Forward PE
n/m
not a meaningful number
Price to sales
0.7×
EV/EBIT
n/m
a loss over the last year
Revenue, 12 months
$8M
−78% on a year ago
Net margin
n/m
outside −100% to 100%
Free cash flow yield
n/m
not a meaningful number

DataMeds AI trades at 0.7× sales. Its trailing earnings are negative, so it has no PE. Revenue was $8M over the last twelve months, down 78% on a year earlier.

Charts

Financials

Income statement for MEDS, by quarter
Income statementQ1 FY24Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
$0$44.5K$5.7M$12.4M$10.9M$7.8M+17392%$3M−47%$1.7M−87%$1.6M−86%$1.8M−77%
Cost of revenue$0$47.1K$5.2M$11.2M$10.2M$7.3M+15352%$2.8M−46%$9.5M−15%$1.4M−86%$1.6M−78%
Gross profit$0−$2.6K$521.2K$1.2M$692.6K$505.8K$231K−56%−$7.9M$170.2K−75%$182.2K−64%
SG&An/an/an/an/a$31.2M$5.2M$31M$4.1M$5.8M−81%$7.2M+38%
−$79.8K−$573K−$1.7M−$3.7M−$31.3M+39201%−$5.5M+860%−$31.5M+1708%−$25.4M+577%−$6M−81%−$7.3M+34%
Interest expense$3.4K$1.3K$137.6K$689.2K$1.1M+32494%$1.2M+90354%$1.4M+936%$875.7K+27%$2.1M+89%$1.6M+32%
Pre-tax income−$83.1K−$574.3K−$1.9M−$4.3M−$32.4M+38916%−$6.7M+1062%−$34.3M+1738%−$27.9M+543%−$7.7M−76%−$18.4M+175%
Net income−$83.1K−$574.3K−$1.9M−$4.3M−$32.4M+38916%−$6.7M+1062%−$34.3M+1738%−$27.9M+543%−$7.7M−76%−$18.4M+175%
$0.00−$0.50−$2.00−$4.50−$31.00−$5.40+980%−$23.00+1050%−$14.50+222%−$3.50−89%−$7.13+32%
894.4K918K968.1K975.4K1M+16%1.2M+35%1.5M+54%1.9M+97%2.1M+102%2.6M+108%

Revenue: Q1 FY24: 6 months less the 3 months printed beside them.

Cost of revenue: Q1 FY24: 6 months less the 3 months printed beside them.

Gross profit: Q1 FY24: 6 months less the 3 months printed beside them.

EPS, diluted: 4 periods, Q1 FY24 to Q4 FY25: quarter's net income to common over its shares, to the cent.

Diluted shares: Q4 FY24 and Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Peers

Companies in Healthcare nearest DataMeds AI's size, closest first.

CompanyMarket capPEIts 10y median PEFwd PEP/SRevenue growthNet margin
MEDSDataMeds AI$5.6Mn/mn/a0.7×−78%n/m
OXBROXBRIDGE RE HOLDINGS$6.5M40.2×9.8×2.4×+40%4.7%
EDUCEducational Development$8.9M5.5×11.3×0.4×−32%8.6%
GTIMGood Times Restaurants$14M6.3×13.5×0.1×−6%1.7%
MDRRMedalist Diversified$17.9M2.9×3.0×1.9×−1%80.2%
VIPVulcan Infrastructure & Power$18.4M16.7×22.5×0.4×−14%1.0%
BCGBinah Capital$18.6M6.8×20.0×0.1×+8%2.2%
MXCMexco Energy$19.2M12.5×13.3×2.8×−9%23.3%
ATCHAtlasClear$20.6M13.6×16.7×1.0×+85%9.8%
CKXCKX Lands$21.9M7.5×32.5×31.5×−17%n/m
MSGMMotorsport Games$22.8M11.5×11.5×1.6×+79%16.2%
Peer median$18.5M9.5×13.4×1.3×−3%8.6%

More on DataMeds AI

Each number over time

Where it ranks

Its groups

About

Industry
Medical - Distribution
Sector
Healthcare

Valuation data, not investment advice. Prices as of .